bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum

C133H111N17Pt4-12 — CID 158031785

IUPACbis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum
SMILESCc1c[c-]c(-c2cc(C)n[n-]2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1c[c-]c(-n2cccn2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1c[c-]c(-n2cccn2)cc1.Cc1cc(C)n(-c2[c-]cc(-c3c(C)cc(-c4ccccc4)cc3C)cc2)n1.Cc1cc(C)n(-c2[c-]cc(-c3c(C)cc(-c4ccccc4)cc3C)cc2)n1.[Pt].[Pt].[Pt].[Pt].[c-]1ccccc1-c1cnc[n-]1.[c-]1ccccc1-c1ncc[n-]1.[c-]1ccccc1-c1nnc[n-]1
InChIInChI=1S/2C25H23N2.2C23H19N2.C11H10N2.2C9H6N2.C8H5N3.4Pt/c2*1-17-14-23(21-8-6-5-7-9-21)15-18(2)25(17)22-10-12-24(13-11-22)27-20(4)16-19(3)26-27;2*1-17-15-21(19-7-4-3-5-8-19)16-18(2)23(17)20-9-11-22(12-10-20)25-14-6-13-24-25;1-8-3-5-10(6-4-8)11-7-9(2)12-13-11;1-2-4-8(5-3-1)9-6-10-7-11-9;1-2-4-8(5-3-1)9-10-6-7-11-9;1-2-4-7(5-3-1)8-9-6-10-11-8;;;;/h2*5-12,14-16H,1-4H3;2*3-11,13-16H,1-2H3;3-5,7H,1-2H3;2*1-4,6-7H;1-4,6H;;;;/q4*-1;4*-2;;;;
InChIKeyXYJUFDDEYDBWIV-UHFFFAOYSA-N
MW2727.78 g/mol
LogP29.75
Rot. Bonds16

About bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum

bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum (PubChem CID 158031785) has the molecular formula C133H111N17Pt4-12 and a molecular weight of 2727.78 g/mol. Its IUPAC name is bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum.

Molecular Properties

Compound Namebis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum
PubChem CID158031785
Molecular FormulaC133H111N17Pt4-12
Molecular Weight2727.78 g/mol
Exact Mass2725.79
IUPAC Namebis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum
SMILESCc1c[c-]c(-c2cc(C)n[n-]2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1c[c-]c(-n2cccn2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1c[c-]c(-n2cccn2)cc1.Cc1cc(C)n(-c2[c-]cc(-c3c(C)cc(-c4ccccc4)cc3C)cc2)n1.Cc1cc(C)n(-c2[c-]cc(-c3c(C)cc(-c4ccccc4)cc3C)cc2)n1.[Pt].[Pt].[Pt].[Pt].[c-]1ccccc1-c1cnc[n-]1.[c-]1ccccc1-c1ncc[n-]1.[c-]1ccccc1-c1nnc[n-]1
InChIInChI=1S/2C25H23N2.2C23H19N2.C11H10N2.2C9H6N2.C8H5N3.4Pt/c2*1-17-14-23(21-8-6-5-7-9-21)15-18(2)25(17)22-10-12-24(13-11-22)27-20(4)16-19(3)26-27;2*1-17-15-21(19-7-4-3-5-8-19)16-18(2)23(17)20-9-11-22(12-10-20)25-14-6-13-24-25;1-8-3-5-10(6-4-8)11-7-9(2)12-13-11;1-2-4-8(5-3-1)9-6-10-7-11-9;1-2-4-8(5-3-1)9-10-6-7-11-9;1-2-4-7(5-3-1)8-9-6-10-11-8;;;;/h2*5-12,14-16H,1-4H3;2*3-11,13-16H,1-2H3;3-5,7H,1-2H3;2*1-4,6-7H;1-4,6H;;;;/q4*-1;4*-2;;;;
InChIKeyXYJUFDDEYDBWIV-UHFFFAOYSA-N
XLogP29.75
TPSA192.13 Ų
H-Bond Donors
H-Bond Acceptors13
Rotatable Bonds16
Heavy Atoms154
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002727.78
LogP ≤ 529.75
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
CID 90702538
11'-Tert-butyl-10-methyl-12-propyl-4',18-bis(trifluoromethyl)spiro[10,11-diaza-13,23-diazoniaoctacyclo[27.2.2.14,8.114,23.122,26.07,14.09,13.016,21]hexatriaconta-1(32),4(36),5,7,9(13),11,16(21),17,19,22,24,26(34),29(33),30-tetradecaene-35,7'-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(8),2,4,9,11-pentaene]
CID 123329303
2-[1-fluoro-2-[5-[2-[2-[1-fluoro-2-(5H-imidazo[2,1-a]isoindol-2-yl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]ethyl]-8-methyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl]ethyl]-5H-imidazo[2,1-a]isoindole
CID 123701571
1-Methyl-2-(1-methylimidazol-2-yl)imidazole;bis(4-methyl-5-(2-methylphenyl)-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);osmium(2+)
CID 140775464
1-Methyl-2-(1-methylimidazol-2-yl)imidazole;bis(4-(2-methylpropyl)-5-phenyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);osmium(2+)
CID 140775499
1-Methyl-2-(1-methylimidazol-2-yl)imidazole;bis(4-methyl-5-phenyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);osmium(2+)
CID 140775502
6-[[2-[3,5-difluoro-4-[4-[3-(3-fluoro-4-propan-2-ylphenyl)pyrazol-1-yl]butan-2-yl]phenyl]-4,5-dimethylimidazol-1-yl]methyl]-2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole
CID 146634253
2-(1,2-Diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;2-(4,5-dimethylimidazol-3-id-2-yl)pyridine;2-imidazol-3-id-2-ylpyridine;hexakis(iridium);2-(5-methylpyrazol-2-id-3-yl)pyridine;hexakis(1-phenylisoquinoline);2-pyrazol-2-id-3-ylpyridine;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
CID 157078080
Tris(6-tert-butyl-1-[3-(trifluoromethyl)pyrazol-1-id-5-yl]isoquinoline);3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(platinum(2+))
CID 157445286
1-Cyclohexyl-5-methyl-2-phenylimidazole;1-(2,4-difluorobenzene-6-id-1-yl)pyrazole;5-(2,6-dimethylphenyl)-1-methyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]imidazole;tetrakis(iridium);1-(4-methylbenzene-6-id-1-yl)-5-phenylpyrazole;2-phenylpyridine
CID 157540868
11'-Tert-butyl-5-[2,6-di(propan-2-yl)phenyl]-4'-methyl-14-(trifluoromethyl)spiro[12,13-diaza-10-azoniatetracyclo[8.6.0.02,7.012,16]hexadeca-1(10),2(7),3,5,8,13,15-heptaene-11,7'-3,5,6-triaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(8),2,4,9,11-pentaene];11'-tert-butyl-8-[2,6-di(propan-2-yl)phenyl]-4'-methyl-14-(trifluoromethyl)spiro[12,13-diaza-10-azoniatetracyclo[8.6.0.02,7.012,16]hexadeca-1(10),2,4,6,8,13,15-heptaene-11,7'-3,5,6-triaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(8),2,4,9,11-pentaene];5-[2,6-di(propan-2-yl)phenyl]-4'-methyl-14-(trifluoromethyl)spiro[12,13-diaza-10-azoniatetracyclo[8.6.0.02,7.012,16]hexadeca-1(10),2(7),3,5,8,13,15-heptaene-11,7'-3,5,6-triaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene]
CID 157630131
2-(1,2-diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;tris(iridium);2-pyrazol-2-id-3-ylpyridine;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;hexakis(1,4,5-trimethyl-3-(10H-phenanthren-10-id-9-yl)-2H-imidazol-1-ium-2-ide)
CID 157715108

Frequently Asked Questions

What is the IUPAC name of bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum?
The IUPAC name of bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum (CID 158031785) is bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum.
What is the SMILES notation for bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum?
The canonical SMILES for bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum is Cc1c[c-]c(-c2cc(C)n[n-]2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1c[c-]c(-n2cccn2)cc1.Cc1cc(-c2ccccc2)cc(C)c1-c1c[c-]c(-n2cccn2)cc1.Cc1cc(C)n(-c2[c-]cc(-c3c(C)cc(-c4ccccc4)cc3C)cc2)n1.Cc1cc(C)n(-c2[c-]cc(-c3c(C)cc(-c4ccccc4)cc3C)cc2)n1.[Pt].[Pt].[Pt].[Pt].[c-]1ccccc1-c1cnc[n-]1.[c-]1ccccc1-c1ncc[n-]1.[c-]1ccccc1-c1nnc[n-]1.
What is the InChIKey of bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum?
The InChIKey is XYJUFDDEYDBWIV-UHFFFAOYSA-N. The full InChI is InChI=1S/2C25H23N2.2C23H19N2.C11H10N2.2C9H6N2.C8H5N3.4Pt/c2*1-17-14-23(21-8-6-5-7-9-21)15-18(2)25(17)22-10-12-24(13-11-22)27-20(4)16-19(3)26-27;2*1-17-15-21(19-7-4-3-5-8-19)16-18(2)23(17)20-9-11-22(12-10-20)25-14-6-13-24-25;1-8-3-5-10(6-4-8)11-7-9(2)12-13-11;1-2-4-8(5-3-1)9-6-10-7-11-9;1-2-4-8(5-3-1)9-10-6-7-11-9;1-2-4-7(5-3-1)8-9-6-10-11-8;;;;/h2*5-12,14-16H,1-4H3;2*3-11,13-16H,1-2H3;3-5,7H,1-2H3;2*1-4,6-7H;1-4,6H;;;;/q4*-1;4*-2;;;;.
What are the key properties of bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum?
bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum has a molecular weight of 2727.78 g/mol, XLogP of 29.75, 16 rotatable bonds, 0 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3,5-dimethylpyrazole);bis(1-[4-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]pyrazole);3-methyl-5-(4-methylbenzene-6-id-1-yl)pyrazol-1-ide;3-phenyl-1,2-diaza-4-azanidacyclopenta-2,5-diene;2-phenylimidazol-3-ide;4-phenylimidazol-3-ide;platinum is sourced from PubChem (CID 158031785), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).